General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Novartis Diagnostics Communications
510-923-5070

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

We Protect Patients

Those who depend on a safe blood supply for their medical care and survival are at the center of everything we do. Our goal is to protect patients with an increasingly broad range of solutions designed to help eradicate transfusion risk.


Learn more


Grifols to acquire Novartis Diagnostics

Grifols and Novartis have announced an agreement for Grifols to acquire the transfusion diagnostics unit of Novartis.

 

Learn more 

 

Powerful Solutions

Proceix TigrisOur products are used to test more than 25 million blood donations a year, reducing HIV-1, hepatitis and West Nile Virus transfusion-related infections.
Learn more about the Procleix Panther System
Learn more about the Procleix Tigris System

 

Now with CE Mark!

The Procleix ® Ultrio Elite ® Assay and Procleix Panther ® System have received CE Mark.

 

Learn more

Stock Chart